| |
NewswireToday - /newswire/ -
Delhi, New Delhi, India, 02/01/2012 - The present report analyzes the global IV iron market, with focus on some of the major regional markets, including the US, Europe and Switzerland - KonceptAnalytics.com.
|
| |
Iron is one of the most important minerals present in the human body and performs the task of carrying oxygen throughout the body through blood, which is then further utilized by the cells to get energy. Decline in iron can therefore lead to certain major problems. Although oral iron supplements can be used to maintain the iron levels in the body, but oral supplements are chronic treatments and generally have poor absorption, poor compliance, and can have certain side effects. In such cases, IV iron therapy proves out to be the best option. Presently, oral iron dominates the global iron market, holding more than half of the market. But with the increasing use of IV iron, its share is expected to increase and surpass that of oral iron.
The global market for IV iron is increasing in the past years. Nephrology remains the largest segment of use for the IV iron therapies, and accounts for more than three-fourths of the overall market. With the ongoing research and development to increase the use of IV iron therapies in other therapeutic areas, including gynaecology, gastroenterology, oncology, chronic heart failures and surgeries, the IV iron market would certainly benefit. There are certain types of IV iron products being marketed and used worldwide, some of which include low molecular weight iron dextran, iron sucrose, ferric gluconate, and ferric carboxylmaltose. The US is the largest IV iron market worldwide, followed by European Union.
The report broadly includes the following:
1. Intravenous (IV) Iron: An Introduction
2. IV Iron Market
2.1 Global Market for Iron Products
2.2 Global IV Iron Market
3. Major IV Iron Regional Markets
3.1 The US IV Iron Market
3.2 European Union Iron Market
4. Growth Drivers
5. Key Issues
6. Company Profiles
6.1 Galenica Pharmaceuticals
6.2 Watson Pharmaceuticals
6.3 AMAG Pharmaceuticals
7. Market Outlook
List of Charts
Global Market for Iron Products (2006-2010)
Global Iron Products Market Share by Segments (2010)
Global IV Iron Market (2006-2010)
IV Iron Market Share by Area of Use (2010)
Global IV Iron Market Share by Major Products (2006-2010)
US IV Iron Replacement Market by Volume (2008-2010)
US IV Iron Replacement Market Volume Share by Category of Use (2010)
US IV Iron Replacement Market Volume Share by Products (2010)
US CKD Patient Profile
US Non-Dialysis IV Iron Market by Quarter (Q110-Q311)
European IV Iron Market by Volume (MAT2007-MAT2011)
IV Iron Usage in Switzerland by Value (2006-2010)
IV Iron Market Volume in Switzerland by Products Categories (2002-2010)
IV Iron Usage in Switzerland Value Share by Therapeutic Area (2010)
IV Iron Usage Growth by Therapeutic Area in Switzerland (2007-2010)
Stages of Chronic Kidney Disease (CKD)
Dialysis Patients Worldwide (2005-2010)
World Population with Diabetes, Age Group 20-79 years (2006-2012)
Ageing Population Worldwide, age>60 year (2008-2014E)
Global Female Population: age 15-44 years (2008-2014E)
IV Iron Avoidance of ESA Initiation in Pre Dialysis Patients
IV Iron Response Rate to ESA Therapy with or without IV Iron
IV Iron Cost Structure by Products
Long & Short Term Concerns about IV Iron
Galenica Pharmaceuticals Revenue Share by Segments (2010)
Vifor Pharma IV Iron Replacement Products Revenue (2009-2010)
Watson Pharmaceuticals Revenue (2007-2010)
Watson Pharmaceuticals Revenue Share by Segments (2010)
AMAG Pharmaceuticals Revenue (2007-2010)
Feraheme Revenue (2009-2010)
Global IV Iron Market Forecasts (2010-2015E)
List of Tables
Comparison of Major IV Iron Preparations
Timeline of IV Iron Development in the US (1932-Present)
IV Iron Products Administration Statistics
IV Iron Products Safety Profile
Dependent & Independent Variables (2006-2010)
Correlation Matrix
Model Summary Coefficient of Determination
Regression Coefficients Output.
|
vikas[.]konceptanalytics.com 
